ERBB2 and breast cancer: Recent knowledge suggest that breast cancer is a heterogeneous disease, with some characteristics, such as Her-2, hormonal receptors, and other variables being a fundamental and critical determinants of clinical outcome, with high prognostic value (Foulkes et al. 2010).